(1 - 19 from 23
)
New targeted molecular therapy takes aim at incurable ...medicalxpress.com › Oncology & Cancer
medicalxpress.com
Scott Tagawa, medical director of the genitourinary oncology program at NewYork-Presbyterian/Weill Cornell Medical Center and The Richard A.
Researchers Awarded $1 Million to Study Optimal Use of ...www.dana-farber.org › Newsroom › News Releases
www.dana-farber.org
Scott Tagawa, the Richard A. Stratton Associate Professor in Hematology and Oncology at Weill Cornell Medicine and medical director of the ...
sorted by relevance / date